Encysive Pharmaceuticals, Inc.
Patent Owner
Stats
- 14 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 15, 2012 most recent publication
Details
- 14 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,196 Total Citation Count
- Oct 21, 1993 Earliest Filing
- 42 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7812038 Carboxylic acid derivatives that inhibit the binding of integrins to their receptorsJun 14, 05Oct 12, 10[A61K]
6972296 Carboxylic acid derivatives that inhibit the binding of integrins to their receptorsOct 09, 01Dec 06, 05[A61K, C07D]
6262084 Compounds that inhibit the binding of integrins to their receptorsOct 14, 99Jul 17, 01[A61K, C07D]
6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptorsOct 14, 99Feb 27, 01[A61K, C07D]
6096773 Compounds that inhibit the binding of integrins to their receptorsApr 15, 99Aug 01, 00[A61K, C07D]
6030991 Benzenesulfonamides and the use thereof to modulate the activity of endothelinDec 06, 96Feb 29, 00[A61K, C07D]
5783705 Process of preparing alkali metal salys of hydrophobic sulfonamidesApr 28, 97Jul 21, 98[C07D]
5594021 Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelinJun 06, 95Jan 14, 97[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7754892 Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamideExpiredAug 03, 07Jul 13, 10[C07D]
2009/0104,265 Polymorphs of N-(4-chloro-3-methyl-5-isoxazolyl) 2-[2-methyl-4,5-(methylenedioxy)phenylacetyl] thiophene-3-sulfonamide, sodium saltAbandonedMar 12, 07Apr 23, 09[A61K, C07D, C07K]
2008/0317,858 FORMULATIONS OF N-(2-ACETYL-4,6-DIMETHYLPHENYL)-3--2-THIOPHENECARBOXAMIDEAbandonedJun 24, 08Dec 25, 08[A61K, A61P]
2008/0188,528 Modulators of C3a receptor and methods of use thereofAbandonedDec 21, 07Aug 07, 08[A61K, C07D, A61P]
2008/0085,313 Methods and compositions for treatment of sleep apneaAbandonedMay 15, 07Apr 10, 08[A61K, A61P]
2008/0086,010 Processes for the preparation of 4-chloro-3-methyl-5-(2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)-3-thi-enylsulfonamido)isoxazoleAbandonedAug 03, 07Apr 10, 08[C07D]
2008/0070,961 Polymorphs of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamideAbandonedAug 03, 07Mar 20, 08[A61K, C07D, A61P]
2008/0026,061 Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenyl-acetyl]-thiophene-3-sulfonamideAbandonedJun 21, 07Jan 31, 08[A61K, C07D, A61P]
7320989 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonistsExpiredAug 23, 04Jan 22, 08[A61K]
7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonistsExpiredFeb 18, 04Jan 15, 08[A61K]
2008/0004,312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonistsAbandonedMay 25, 07Jan 03, 08[A61K, C07D, A61P]
7288538 Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsExpiredAug 23, 04Oct 30, 07[A61K]
2007/0232,671 Methods and compositions for treatment of diastolic heart failureAbandonedMar 12, 07Oct 04, 07[A61K]
7265122 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonistsExpiredFeb 20, 04Sep 04, 07[C07D]
2007/0060,608 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compoundsAbandonedNov 07, 03Mar 15, 07[A61K]
6723711 Propanoic acid derivatives that inhibit the binding of integrins to their receptorsExpiredOct 09, 01Apr 20, 04[A61K, C07D, A61D]
6713604 Process to inhibit binding of the integrin .alpha.4.beta.1 , to VCAM-1 fibronectin and cyclic peptides thereofExpiredMay 08, 96Mar 30, 04[C07K]
6686382 Sulfonamides and derivatives thereof that modulate the activity of endothelinExpiredDec 29, 00Feb 03, 04[A61K, C07D, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.